WNK2 and B-cell non-Hodgkin lymphoma: Among these pathways, the Mitogen-activated protein kinase (MAPK) pathway is the most significantly enriched and the most biologically relevant pathway, with previous studies showing that this pathway is modulated by R in sensitizing B-cell lymphomas to chemotherapy (47, 48).